[go: up one dir, main page]

CL2014000792A1 - Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio - Google Patents

Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio

Info

Publication number
CL2014000792A1
CL2014000792A1 CL2014000792A CL2014000792A CL2014000792A1 CL 2014000792 A1 CL2014000792 A1 CL 2014000792A1 CL 2014000792 A CL2014000792 A CL 2014000792A CL 2014000792 A CL2014000792 A CL 2014000792A CL 2014000792 A1 CL2014000792 A1 CL 2014000792A1
Authority
CL
Chile
Prior art keywords
magnesium
promotion
composition
retention
absorption
Prior art date
Application number
CL2014000792A
Other languages
English (en)
Inventor
Clara Garcia-Rodenas
Matthias Hoppler
Cavin Elizabeth Offord
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47022680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014000792(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of CL2014000792A1 publication Critical patent/CL2014000792A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)
CL2014000792A 2011-10-18 2014-03-31 Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio CL2014000792A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11185610 2011-10-18

Publications (1)

Publication Number Publication Date
CL2014000792A1 true CL2014000792A1 (es) 2014-08-22

Family

ID=47022680

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014000792A CL2014000792A1 (es) 2011-10-18 2014-03-31 Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio

Country Status (15)

Country Link
US (1) US9781947B2 (es)
EP (1) EP2768313B2 (es)
CN (1) CN103906435B (es)
AU (1) AU2012324993B2 (es)
BR (1) BR112014007829A2 (es)
CL (1) CL2014000792A1 (es)
ES (1) ES2546262T5 (es)
MX (1) MX354727B (es)
PH (1) PH12014500344A1 (es)
PL (1) PL2768313T3 (es)
PT (1) PT2768313E (es)
RU (1) RU2604502C2 (es)
TW (1) TW201316993A (es)
WO (1) WO2013057072A1 (es)
ZA (1) ZA201403592B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011005681A1 (en) 2009-07-06 2011-01-13 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
US10857167B2 (en) 2015-04-28 2020-12-08 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
EP3493686B1 (en) 2016-08-04 2024-03-27 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
AU2018387291B2 (en) 2017-12-21 2024-10-10 Societe Des Produits Nestle S.A. Compositions for use in the promotion of intestinal muscle growth and development and associated intestinal motility
WO2020033708A1 (en) * 2018-08-08 2020-02-13 Mars, Incorporated Pet food products comprising oligosaccharides and methods of use
CN114145458A (zh) * 2021-11-29 2022-03-08 内蒙古伊利实业集团股份有限公司 棕榈酸甘油酯在制备改善或促进人体镁吸收的组合物中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
JPH08283162A (ja) 1995-04-10 1996-10-29 Snow Brand Milk Prod Co Ltd ミネラル吸収促進剤
US5939394A (en) * 1996-01-18 1999-08-17 Fleming & Company Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections
US5906982A (en) * 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
GB0028238D0 (en) 2000-11-20 2001-01-03 Cerestar Holding Bv Indigestible oligosaccharides and magnesium absorption in humans
US7435431B2 (en) * 2004-07-28 2008-10-14 Abbott Laboratories Method for controlling body weight in estrogen-insufficient women
RU2430631C2 (ru) * 2006-02-10 2011-10-10 Нестек С.А. Пребиотическая смесь олигосахаридов и пищевой продукт, ее содержащий
AU2007222598B2 (en) * 2006-03-07 2013-01-10 Société des Produits Nestlé S.A. Synbiotic mixture
ES2634613T3 (es) * 2006-08-30 2017-09-28 Prolacta Bioscience, Inc. Métodos de obtención de leche estéril y composiciones de la misma
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
MX2010009978A (es) * 2008-03-14 2010-11-30 Nestec Sa Mezcla simbiotica.
WO2010068086A1 (en) * 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
HUE068442T2 (hu) * 2009-07-15 2024-12-28 Nutricia Nv Az immunrendszer stimulálására szolgáló, emészthetetlen oligoszacharidok keveréke
AU2010329990B2 (en) * 2009-12-08 2015-07-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
EP2455387A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
CA2836241A1 (en) 2011-06-08 2012-12-13 Nestec S.A. Nutritional compositions having exogenous milk fat globule membrane components

Also Published As

Publication number Publication date
US20140255543A1 (en) 2014-09-11
RU2604502C2 (ru) 2016-12-10
WO2013057072A1 (en) 2013-04-25
AU2012324993A2 (en) 2014-06-12
ES2546262T5 (es) 2019-04-12
EP2768313B1 (en) 2015-08-12
US9781947B2 (en) 2017-10-10
CN103906435B (zh) 2016-11-23
MX2014004709A (es) 2015-02-05
ES2546262T3 (es) 2015-09-22
ZA201403592B (en) 2015-12-23
CN103906435A (zh) 2014-07-02
AU2012324993B2 (en) 2015-11-26
EP2768313B2 (en) 2019-01-02
EP2768313A1 (en) 2014-08-27
PH12014500344A1 (en) 2014-04-14
MX354727B (es) 2018-03-16
PL2768313T3 (pl) 2016-02-29
BR112014007829A2 (pt) 2017-04-18
PT2768313E (pt) 2015-10-14
AU2012324993A1 (en) 2014-02-27
TW201316993A (zh) 2013-05-01
RU2014119845A (ru) 2015-11-27

Similar Documents

Publication Publication Date Title
CO6870005A2 (es) Composición anti-cgrp y uso de las mismas
BRPI0822104A2 (pt) Composições antimicrobianas e métodos para o uso das mesmas
BR112013001423A2 (pt) método, método in vitro, uso e kit útil para realizar o método
BR112013016299A2 (pt) artigo abrasivo; e método para formar o mesmo
CO6831975A2 (es) Inmunoconjugados, composiciones para prepararlos, métodos para prepararlos y uso
PL3199024T3 (pl) Zastosowanie kompozycji cyklodekstryny i stosowne sposoby
BR112013010988A2 (pt) composição fluída e uso
CO6801796A2 (es) Composiciones de tratamiento de pozo de liberación retardada para uso en fluídos de tratamiento de pozo
CO6801774A2 (es) Compuestos de benzotiazol y su uso farmacéutico
CO6900118A2 (es) Métodos para tratar el cancer por el uso de antagonistas de unión al eje pd-1e inhibidores de mek
PL3269386T3 (pl) Związki glinu do stosowania w środkach terapeutycznych i szczepionkach
BRPI0911297A2 (pt) composição e métodos para preparo e uso das mesmas
BR112013010272A2 (pt) métodos analíticos e arranjos para uso nos mesmos
BR112013034055A2 (pt) alcaftadina para uso no tratamento de urticária
BR112015002706A2 (pt) niclosamida e seus derivados para uso no tratamento de tumores sólidos
BR112013015378A2 (pt) misturador dinâmico e seu uso
BR112014005406A2 (pt) composição de vacina e respectivo uso
CO6781486A2 (es) Compuestos y su uso
CL2014000792A1 (es) Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio
BR112015027026A8 (pt) composição para uso na redução da formação de casca e na promoção da cicatrização
CR20140362A (es) Fenilimidazopirazoles sustituidos y su uso
BR112012024996A2 (pt) uso de pelo menos um tiossulfinato ou tiossulfinato de tiossulfinato de dialquila para reduzir o número de apicompelox em um animal
EP3075379A4 (en) Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same
BR112014004297A2 (pt) compostos para uso em reforço da coagulação
FI20115283A0 (fi) Alkalisesti aktivoitu betonikoostumus ja sen käyttö valetuissa betonielementeissä